US2022177572A1PendingUtilityA1
Restricted immunoglobulin heavy chain mice
Est. expiryOct 17, 2031(~5.2 yrs left)· nominal 20-yr term from priority
C12N 2800/204C12N 15/8509A01K 67/0278C07K 2317/21C07K 2317/20C07K 2317/56A61P 31/04C07K 2317/565C07K 16/00C07K 16/461C07K 2317/10A61P 31/10C12N 5/10C07K 16/28C07K 2317/515C07K 2317/24A01K 2217/072A01K 2217/15A01K 2227/105A61P 31/12A01K 2267/01C07K 2317/52C07K 2317/567
79
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Mice having a restricted immunoglobulin heavy chain locus are provided, wherein the locus is characterized by a single polymorphic human VH gene segment, a plurality of human DH gene segments and a plurality of JH gene segments. Methods for making antibody sequences that bind an antigen (e.g., a viral antigen) are provided, comprising immunizing a mouse with an antigen of interest, wherein the mouse comprises a single human VH gene segment, a plurality of human DH gene segments and a plurality of JH gene segments, at the endogenous immunoglobulin heavy chain locus.
Claims
exact text as granted — not AI-modified1 . A rat or mouse having a restricted immunoglobulin heavy chain locus characterized by the presence of a single human V H gene segment, one or more human D H gene segments, and one or more human J H gene segments.
2 . The rat or mouse of claim 1 , wherein the mouse comprises a deletion of all or substantially all endogenous V H , D H , and J H gene segments.
3 . The mouse of claim 1 , wherein the single human V H gene segment is selected from V H 1-2, V H 1-69, V H 2-26, V H 2-70, V H 3-23.
4 .- 5 . (canceled)
6 . The rat or mouse of claim 1 , wherein the single human V H gene segment is operably linked to a human or non-human immunoglobulin constant region gene.
7 . The rat or mouse of claim 6 , wherein the single human V H gene segment is operably linked to a mouse, rat, or human constant region gene.
8 . The rat or mouse of claim 1 , further comprising a one or more human immunoglobulin V L gene segments operably linked to one or more human J L gene segments.
9 . The rat or mouse of claim 8 , wherein the one or more human V L gene segments and/or the one or more human J L gene segments are selected from human κ and human λ gene segments.
10 . The rat or mouse of claim 8 , wherein the one or more human immunoglobulin V L gene segments and the one or more human J L gene segments are operably linked to a non-human light chain constant gene.
11 . The rat or mouse of claim 10 , wherein the non-human light chain constant gene is selected from a mouse κ or λ constant region gene.
12 . A mouse comprising, in its germline, a replacement at an endogenous immunoglobulin heavy chain locus of all or substantially all endogenous V H , D H , and J H gene segments with single human V H gene segment and/or polymorphic variants thereof, one or more human D H gene segments and one or more human J H gene segments.
13 . The mouse of claim 12 , further comprising a replacement at an endogenous immunoglobulin light chain locus of all or substantially all endogenous V L and J L gene segments with one or more human V L and one or more human J L gene segments.
14 . (canceled)
15 . A cell or tissue derived from the rat or mouse of claim 1 .
16 . A method of making a nucleic acid sequence encoding a human V H domain, comprising
(a) immunizing a rat or mouse of claim 1 with an antigen of interest; (b) allowing said mouse to mount an immune response to the antigen of interest; and, (c) obtaining a nucleic acid sequence encoding a human V H domain from said mouse.
17 .- 19 . (canceled)
20 . The method of claim 16 , wherein the immunoglobulin V H region sequence is at least 95% identical to SEQ ID NO: 60, SEQ ID NO: 62, SEQ ID NO: 64, SEQ ID NO: 66 or SEQ ID NO: 68.
21 . The method of claim 16 , wherein the immunoglobulin V H region sequence comprises SEQ ID NO: 60, SEQ ID NO: 62, SEQ ID NO: 64, SEQ ID NO: 66, SEQ ID NO: 68. or a polymorphic variant thereof.
22 . The method of claim 16 , wherein the immunoglobulin V H region sequence encodes a protein that is at least 95% identical with SEQ ID NO: 61, SEQ ID NO: 63, SEQ ID NO: 65, SEQ ID NO: 67 or SEQ ID NO: 69.
23 . The method of claim 16 , wherein the method further comprises making a nucleic acid sequence encoding a human V L domain that is cognate with the human V H domain, comprising isolating a B cell encoding the human V H domain and the human V L domain from said mouse and obtaining therefrom the sequence of the heavy and light chain variable domains.
24 . The method of claim 23 , wherein the human V L domain is a V κ domain.
25 . The method of claim 16 , wherein the mouse comprises a deletion of the endogenous immunoglobulin heavy chain locus and the endogenous κ light chain.
26 . A rat or mouse comprising an endogenous immunoglobulin heavy chain locus, wherein the endogenous immunoglobulin heavy chain locus consists essentially of
a) one or more polymorphic variants of a single human V H gene segment, b) one or more human D H gene segments, and c) one or more human J H gene segments, wherein the single human V H gene segment is a polymorphic V H gene segment associated with a high copy number in human populations, and wherein the single human V H gene segment, one or more human D H gene segments, and one or more J H gene segments are operably linked to a non-human immunoglobulin heavy chain constant region gene.
27 . A cell or tissue derived from the rat or mouse of claim 26 .
28 . A method of making a nucleic acid sequence encoding a human V H domain, comprising
(a) immunizing a rat or mouse of claim 26 with an antigen of interest; (b) allowing said mouse to mount an immune response to the antigen of interest; and, (c) obtaining a nucleic acid sequence encoding a human V H domain from said mouse.Join the waitlist — get patent alerts
Track US2022177572A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.